We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nanobone Material Activates Natural Repair Signals to Regrow Bone

By HospiMedica International staff writers
Posted on 04 Sep 2026

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. More...

Repairing the resulting jawbone gap often requires invasive bone grafting at 10 to 12 years of age, with lasting effects on speech and self-confidence. Surgeons have had few alternatives for decades. To help address this challenge, University of Sydney researchers have developed a biodegradable “nanobone” material intended to prompt the body to regrow bone.

The biodegradable nanobone is a calcium‑aluminosilicate nanomaterial created at the University of Sydney’s School of Dentistry with contributions from the Charles Perkins Centre and Sydney Nano, in collaboration with the University of Queensland. The study was published in ACS Nano in 2026. The approach aims to provide a future alternative to grafts that have changed little in more than 50 years and often require harvesting autologous bone.

The material is designed to teach the body to heal itself. Instead of supplying manufactured growth factors, it activates latent transforming growth factor beta 1 (TGF‑β1) that is already present in tissue. This activation recruits bone‑forming stem cells to the defect and supports their maturation into bone‑producing cells. The nanomaterial also promotes rapid blood clotting in about 30 seconds, which helps stabilize the site in the earliest phase of repair.

In a preclinical bone model, the nanobone generated approximately 80 percent more new bone than a material control after eight weeks. It also increased activation of a key bone‑repair growth factor to about 10 times the level achieved with conventional methods. The authors note that more than four million bone repair procedures are performed globally each year, underscoring the scale of the clinical need.

According to the investigators, this is the first demonstration of a single nanomaterial platform that combines rapid hemostasis, activation of endogenous growth signals, stem‑cell recruitment, and enhanced bone regeneration. While further testing is required before human trials, potential applications could extend beyond cleft lip and palate to traumatic injuries, tooth loss, and other difficult‑to‑repair defects. The team is also exploring integration with personalized three‑dimensional printed scaffolds tailored to individual patient anatomy.

“The material activates dormant repair signals in the body, triggering a cascade of healing processes that attract bone-forming stem cells and stimulate new bone growth,” said Associate Professor Chun Xu, Sydney Horizon Fellow in the Faculty of Medicine and Health.

“Every patient is different and every bone defect is different. In the future, we hope to combine these materials with advanced 3D-printing technologies so treatments can be tailored to the specific needs of each patient,” added Prof. Xu.

Related Links
University of Sydney’s School of Dentistry
 


New
Gold Member
Breast Imaging Monitor
Barco Coronis Onelook MDMC-32133 32MP
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Hybrid Arch Device
Neo EDE
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.